Machine Learning’s Prediction of Liver Cancer Risk in Metabolic Liver Disease
The intersection of machine learning (ML) and healthcare continues to revolutionize medical practices, with recent advancements focusing on predicting cancer risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers from UC Davis Health have developed an ML tool to identify individuals at heightened risk of developing hepatocellular carcinoma (HCC), a prevalent form of […]
Machine Learning’s Prediction of Liver Cancer Risk in Metabolic Liver Disease Read More »
